Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

被引：0
|
作者：
Fujimoto, N. [1 ]
Aoe, K. [2 ]
Kozuki, T. [3 ]
Oze, I. [4 ]
Kato, K. [5 ]
Kishimoto, T. [1 ]
Hotta, K. [6 ]
机构：
[1] Okayama Rosai Hosp, Okayama, Japan
[2] Yamaguchi Ube Med Ctr, Ube, Yamaguchi, Japan
[3] Shikoku Canc Ctr Hosp, Matsuyama, Ehime, Japan
[4] Aichi Canc Ctr, Res Inst, Nagoya, Aichi, Japan
[5] Kawasaki Med Coll, Okayama, Japan
[6] Okayama Univ Hosp, Okayama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
programmed death-1; immune checkpoint inhibitor; asbestos;
D O I：
10.1016/j.jtho.2018.08.1265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-10
引用
收藏
页码：S746 / S746
页数：1
相关论文
共 50 条
  • [31] Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Chemonaive Patients With Unresectable Malignant Pleural Mesothelioma
    Tsao, Anne S.
    Harun, Nusrat
    Lee, J. Jack
    Heymach, John
    Pisters, Katherine
    Hong, Waun Ki
    Fujimoto, Junya
    Wistuba, Ignacio
    CLINICAL LUNG CANCER, 2014, 15 (03) : 197 - 201
  • [32] Pemetrexed for diffuse malignant pleural mesothelioma
    Manegold, C
    Aisner, J
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 30 - 35
  • [33] Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
    Tsao, Anne S.
    Moon, James
    Wistuba, Ignacio I.
    Vogelzang, Nicholas J.
    Kalemkerian, Gregory P.
    Redman, Mary W.
    Gandara, David R.
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : 1299 - 1308
  • [34] Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
    Ceresoli, Giovanni L.
    Zucali, Paolo A.
    De Vincenzo, Fabio
    Gianoncelli, Letizia
    Simonelli, Matteo
    Lorenzi, Elena
    Ripa, Cristina
    Giordano, Laura
    Santoro, Armando
    LUNG CANCER, 2011, 72 (01) : 73 - 77
  • [35] Pemetrexed therapy for malignant pleural mesothelioma
    Puto, K
    Garey, JS
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (04) : 678 - 683
  • [36] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Santoro, A.
    Ceresoli, G. L.
    Marangolo, M.
    Mencoboni, M.
    Zucali, P.
    Favaretto, A.
    Grossi, F.
    Bearz, A.
    Botta, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S18 - S18
  • [37] ONCOS-102 and pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma
    Ponce Aix, S.
    Viteri, S.
    Bosch-Borrera, J.
    Kuryk, L.
    Hakonen, T.
    Vetrhus, S.
    Jaderberg, M.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Outcomes of patients with malignant pleural mesothelioma treated with first line palliative cisplatin and pemetrexed chemotherapy, in South Yorkshire
    Taylor, F.
    Viggars, A.
    Daniels, S.
    Danson, S. J.
    Fisher, P. M.
    Hatton, M. Q.
    Lee, C. E.
    Woll, P. J.
    LUNG CANCER, 2015, 87 : S20 - S20
  • [39] Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: A phase I/II study in Japanese patients
    Nakagawa, Kazuhiko
    Yamazaki, Koichi
    Kunitoh, Hideo
    Hida, Toyoaki
    Gemba, Kenichi
    Shinkai, Tetsu
    Ichinose, Yukito
    Adachi, Susumu
    Nambu, Yoshihiro
    Saijo, Nagahiro
    Fukuoka, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (05) : 339 - 346
  • [40] Interaction and cross resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines
    Kitazono, Miyako
    Takiguch, Yuichi
    Kitazono, Satoru
    Ashinuma, Hironori
    Kitamura, Atsushi
    Tada, Yuji
    Kurosu, Katsushi
    Sakaida, Emiko
    Sekine, Ikuo
    Tanabe, Nobuhiro
    Tagawa, Masatoshi
    Tatsumi, Koichiro
    CANCER RESEARCH, 2012, 72
12345